Trial · NCT00088413
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Breast Cancer Cohort | Complete Response | 1 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Ovarian Cancer Cohort | Complete Response | 0 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Breast Cancer Cohort | Partial Response | 0 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Ovarian Cancer Cohort | Partial Response | 0 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Breast Cancer Cohort | Stable Disease | 4 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Ovarian Cancer Cohort | Stable Disease | 3 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Breast Cancer Cohort | Progressive Disease | 7 | Participants | |
| Number of Participants With Complete Responses (CRs), Partial Responses (PRs,) Stable Disease and Progressive Disease in the Ovarian Cancer and Breast Cancer Cohorts | Ovarian Cancer Cohort | Progressive Disease | 11 | Participants | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Injection-site reaction | 88 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Fatigue | 5 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Fever | 3 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Hemoglobin/Anemia | 1 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Hypoalbuminemia | 1 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Alk Phos | 1 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Syncope | 0 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Anorexia | 1 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Vomiting | 1 | Percentage of vaccines | |
| Percentage of Vaccines Associated With Grade 1 and Grade 2 Adverse Events Related to Vaccine in the Colorectal Cancer and Non-Colorectal Cancer Arm/Group | Colorectal Cancer and Non-Colorectal Cancer Cohort | Hot flushes/flashes | 1 | Percentage of vaccines | |
| Percentage of Participants With Grade 1 and Grade 2 Adverse Events Possibly, Likely, or Definitely Related to Vaccine in the Breast Cancer and Ovarian Cancer Cohorts | Breast Cancer and Ovarian Cancer Cohorts | Injection-site reaction | 22 | percentage of participants | |
| Percentage of Participants With Grade 1 and Grade 2 Adverse Events Possibly, Likely, or Definitely Related to Vaccine in the Breast Cancer and Ovarian Cancer Cohorts | Breast Cancer and Ovarian Cancer Cohorts | Musculoskeletal pain | 2 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00088413/results